Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 2.36Cr 2.1Cr 1.95Cr 1.77Cr 3.34Cr 224.22Cr 3.4Cr 23Cr 9.17Cr 117.01Cr 8.87Cr 8.68Cr 373Cr P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 4.22Cr 3.75Cr 3.48Cr 3.16Cr 5.97Cr 400.36Cr 6.06Cr 42Cr 16Cr 208.93Cr 16Cr 15Cr 666.02Cr EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/17/05 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/17/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/17/14 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/16/14 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/16/05 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/16/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/16/08 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/16/01 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/15/10 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/15/04 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/15/02 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 week+82.61%
Current month+90.91%
1 month+90.91%
3 months+20.00%
Current year+27.27%
1 month 0
Extreme 0.0022
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+82.61%-46.15%+250.00% 9L
0.00%-4.21%-34.30%-54.95% 167.7Cr
+1.16%-0.75% - - 152.5Cr
+5.56%+18.09%-36.85%+32.35% 114.49Cr
+0.39%-0.29%-32.59%+143.55% 112.95Cr
-0.81%-2.09%+34.93%+43.35% 98Cr
+0.81%-11.02%+159.39%+715.35% 83Cr
-1.51%-5.41%+3.25%+162.96% 72Cr
-7.08%-20.82%-21.89%+23.62% 66Cr
-1.90%-7.59%+29.78%-38.98% 51Cr
Average -0.34%-2.74%+6.17%+141.92% 91.72Cr
Weighted average by Cap. +0.19%-1.88%+4.38%+112.14%

Financials

2015 2016
Net sales 2.55Cr 2.27Cr 2.1Cr 1.91Cr 3.6Cr 241.84Cr 3.66Cr 25Cr 9.89Cr 126.2Cr 9.56Cr 9.36Cr 402.3Cr 3.23Cr 2.87Cr 2.66Cr 2.42Cr 4.57Cr 306.83Cr 4.65Cr 32Cr 13Cr 160.12Cr 12Cr 12Cr 510.43Cr
Net income 54.95L 48.84L 45.27L 41.19L 77.72L 52Cr 78.97L 5.44Cr 2.13Cr 27Cr 2.06Cr 2.02Cr 87Cr 20.61L 18.32L 16.98L 15.45L 29.16L 20Cr 29.62L 2.04Cr 80.04L 10Cr 77.36L 75.71L 33Cr
Net Debt 2.48Cr 2.2Cr 2.04Cr 1.86Cr 3.51Cr 235.41Cr 3.56Cr 25Cr 9.63Cr 122.85Cr 9.31Cr 9.11Cr 391.62Cr 1.86Cr 1.65Cr 1.53Cr 1.39Cr 2.63Cr 176.15Cr 2.67Cr 18Cr 7.21Cr 92Cr 6.97Cr 6.82Cr 293.03Cr
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. AOXG Stock